The authors reply

Kidney Int. 2020 Jan;97(1):213-214. doi: 10.1016/j.kint.2019.09.027.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Benzhydryl Compounds
  • Diabetes Mellitus, Type 2*
  • Glucosides
  • Hemodynamics
  • Humans
  • Renal Insufficiency, Chronic*

Substances

  • Benzhydryl Compounds
  • Glucosides
  • empagliflozin